Microbot Medical

Martin J. Madden appointed to Microbot Medical's Board of Directors

Mr. Madden’s diversified and extensive R&D experience in the development of medical devices includes hundreds of projects in multiple medical spaces, many of which reached successful commercialization stage.  Mr. Madden recently retired from Johnson & Johnson after a 30 year career.

Joint research to evaluate self-cleaning shunt device designed to prevent obstruction in cerebrospinal fluid catheters

On Monday, Microbot Medical announced its research collaboration agreement with Washington University School of Medicine. Microbot Medical expects that the studies, which will be administered by recognized experts in the field of Hydrocephalus, will be completed in 2018.

BioSpace website: Microbot Medical Ltd. (Yokneam) and StemCells (STEM) Announce Strategic Merger

More information: Voting agreement (lawinsider.com), a followup article (biospace.com) and an article explain why the merger happened by Alexander Maxwell of the Seeking Alpha web site.